Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Sell
1,624
-74
-4% -$13.4K ﹤0.01% 1523
2026
Q1
$261K Buy
+1,698
New +$230K ﹤0.01% 1574
2025
Q4
Sell
-11,162
Closed -$1.48M 1661
2025
Q3
$1.48M Buy
11,162
+637
+6% +$87.5K 0.01% 670
2025
Q2
$1.5M Buy
10,525
+1,841
+21% +$261K 0.02% 605
2025
Q1
$1.33M Buy
+8,684
New +$1.36M 0.02% 616
2024
Q1
Sell
-19,740
Closed -$2.07M 1350
2023
Q4
$2.07M Buy
19,740
+6,634
+51% +$613K 0.05% 370
2023
Q3
$1.24M Buy
+13,106
New +$1.34M 0.04% 451

Other funds holding DVA

Vident Advisory's DVA Position: Q2 2026 in Review

Vident Advisory reduced its DaVita (DVA) stake by 4.4% in Q2 2026, selling an estimated $13.4K and leaving 1,624 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1523.

Vident Advisory first reported a position in DVA in Q3 2023 and has held it in 7 quarters since. The position peaked at $2.07M in Q4 2023. 630 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Vident Advisory held 1,624 shares of DaVita worth $361K as of Q2 2026.
  • Vident Advisory sold 74 DaVita shares in Q2 2026, an estimated $13.4K.
  • DaVita made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1523 holding.
  • Vident Advisory first reported a position in DaVita in Q3 2023 and has held it in 7 quarters since.
  • Vident Advisory's DaVita position peaked at $2.07M in Q4 2023.
  • 630 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.